Guangzhou Baiyunshan Pharmaceutical saw the highest growth of 1.99% in patent filings and 1.61% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.04% and grants by 0.33%. GlobalData’s DataBook provides a comprehensive analysis of Guangzhou Baiyunshan Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Guangzhou Baiyunshan Pharmaceutical has been focused on protecting inventions in United States(US) with 26 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 21% filings and 68% grants. The World Intellectual Property Organization(WIPO), China(CN), United States(US), and Australia(AU) patent Office are among the top ten patent offices where Guangzhou Baiyunshan Pharmaceutical is filings its patents. Among the top granted patent authorities, Guangzhou Baiyunshan Pharmaceutical has 68% of its grants in United States(US) and 32% in China(CN).
Roche and Johnson & Johnson could be the strongest competitors for Guangzhou Baiyunshan Pharmaceutical
Patents related to health & wellness and climate change lead Guangzhou Baiyunshan Pharmaceutical's portfolio
Guangzhou Baiyunshan Pharmaceutical has the highest number of patents in health & wellness followed by, climate change and meat & seafood alternatives. For health & wellness, nearly 14% of patents were filed and 17% of patents were granted in Q2 2024.
Animal feed inputs related patents lead Guangzhou Baiyunshan Pharmaceutical portfolio followed by anesthesia and respiratory devices, and communications
Guangzhou Baiyunshan Pharmaceutical has highest number of patents in animal feed inputs followed by anesthesia and respiratory devices, communications, mobiles, hand-helds, pdas, smartphones, and solid tumor.
For comprehensive analysis of Guangzhou Baiyunshan Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
